Field safety notices: Saladax Biomedical Inc.
Manufacturer registered in EUDAMED: SRN US-MF-000007957 ; country: United States
3 authority publications by 2 authorities, from 28 Feb 2020 to 31 Aug 2026.
Latest notice: 31 Aug 2026, MHRA, MyCare Insite Total Aripiprazole Test
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Saladax Biomedical Inc. or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
2 distinct corrective actions.
- MHRAUnited Kingdomofficial source: MyCare Insite Total Aripiprazole Test, MHRA, 2026-08-31MyCare Insite Total Aripiprazole Test
Source: MHRA, Field Safety Notices, gov.uk (Open Government Licence v3.0) Contains public sector information licensed under the Open Government Licence v3.0. · collected 16 Nov 2026
Corrective action: 2 publications by AEMPS, from 28 Feb 2020 to 5 Mar 2020
- MyCare Insite Clozapine Test. Referencia: CLZ-MCI
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- MyCare Insite Clozapine Test. Referencia: CLZ-MCI
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026